Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

johnson_and_johnson_jj

EU orders nearly 40 million more J&J COVID vaccines

July 7, 2021 Research and Development

The EU has ordered nearly 40 million more doses of the J&J COVID-19 vaccines for European countries. This is despite …
News
boehringer_biberach_germany_copy

Breakthrough heart failure drug meets primary endpoint

July 7, 2021 Research and Development

The Phase III trial for empagliflozin, a treatment for patients with heart failure with preserved ejection fraction, has met its …
News

PrecisionLife appoints Ray Pawlicki as Executive Chair to the board of directors

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PrecisionLife Limited has appointed Ray Pawlicki, previously CIO at Biogen and Novartis, as Executive Chair to the board of directors.Widely …
Appointment
golo_von_basum

New Chief Operating Officer for Dutch MedTech STENTiT

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medical device company STENTiT has appointed Dr Golo von Basum as its Chief Operating Officer.He will be responsible for the …
Appointment
christian_dillon

Christian Dillon announced as Vice President of Biology at PhoreMost

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PhoreMost has announced the appointment of Dr Christian Dillon as Vice President of Biology.In this new role, Dr Dillon will …
Appointment
serap_becker

Ashfield Engage appoints new Head of Patient Solutions

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield Engage, part of UDG Healthcare plc, has appointed Serap Becker as Head of Patient Solutions for the DACH region.Joining …
Appointment
pers

Personalised medicine in oncology: Where are we now?

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …
Feature

Novartis appoints Alessandra Dorigo as General Manager

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …
Appointment
close-up-of-female-hands-holding-medication-bottle-royalty-free-image-1612294037

Exploring the potential of drug repurposing

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug repurposing

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …
Feature

“Worst drug approval decision in recent US history”

June 30, 2021 Research and Development

The FDA’s decision to accelerate approval for Aduhelm, the first new drug for Alzheimer’s in two decades, has been met …
News
img_4190-e1376666350337-web

Sickle cell therapy granted innovation passport by MHRA

June 30, 2021 Research and Development MHRA, SCD, brexit

Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …
News
bms_european_hq_in_rueil_1

EU approves BMS’s treatment for metastatic colorectal cancer

June 30, 2021 Research and Development

The EU has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the treatment of metastatic colorectal cancer. The treatment will be …
News
xxx

RNA breakthrough: Fluorescence used to track molecule movement

June 30, 2021 Research and Development AstraZeneca, RNA, mrna

Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …
News

EU approves Merck’s treatment for oesophageal cancer

June 30, 2021 Research and Development

The EU has approved Merck’s KEYTRUDA, in combination with platinum- and fluoropyrimidine-based chemotherapy, as treatment for advanced oesophageal cancer. The …
News

Anti-parasitic drug investigated as potential COVID treatment

June 23, 2021 Research and Development

The University of Oxford has announced that it has begun investigations into ivermectin, a controversial anti-parasitic drug, as a potential …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025